ArticleJournal of immunotherapy and precision oncology2020

Ramucirumab and Docetaxel in Patients with Metastatic Urothelial Carcinoma Harboring Fibroblast Growth Factor Receptor Alterations: A Case Series and Literature Review.

Katherine Emilie Rhoades Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.